These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13890520)

  • 21. The chromatographic behaviour of wasp venom kinin, kallidin and bradykinin.
    MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1958 Sep; 13(3):326-9. PubMed ID: 13584738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The extraction of human urinary kinin (substance Z) and its relation to the plasma kinins.
    GADDUM JH; HORTON EW
    Br J Pharmacol Chemother; 1959 Mar; 14(1):117-24. PubMed ID: 13651588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release and inactivation of kinins.
    Erdös EG
    Gastroenterology; 1966 Nov; 51(5):893-900. PubMed ID: 5923209
    [No Abstract]   [Full Text] [Related]  

  • 24. Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.
    Maier M; Reissert G; Jerabek I; Bergmann I; Balaun E; Lottspeich F; Binder BR
    Biochem Pharmacol; 1990 Feb; 39(3):549-53. PubMed ID: 2306266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
    Hecquet C; Tan F; Marcic BM; Erdös EG
    Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
    Spragg J; Vavrek RJ; Stewart JM
    Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ENDOGENEOUS MECHANISMS IN INCREASED VASCULAR PERMEABILITY IN INFLAMMATION.
    HAYASHI H
    Acta Pathol Jpn; 1963 Oct; 13():213-5. PubMed ID: 14195178
    [No Abstract]   [Full Text] [Related]  

  • 29. THE RELEASE OF VASCULAR PERMEABILITY FACTORS BY HOMOLOGOUS ANTIGEN AND BY SOLUBLE ANTIGEN-ANTIBODY COMPLEXES IN TISSUE CULTURE AND ITS BIOLOGIC SIGNIFICANCE.
    HAYASHI H; KINUWAKI Y; KOONO M; TAKABA Y
    Lab Invest; 1964 Sep; 13():1124-38. PubMed ID: 14207887
    [No Abstract]   [Full Text] [Related]  

  • 30. A high performance liquid chromatographic method for the determination of kinin releasing activity of kallikrein.
    Gau W; Haberland GL; Ploschke HJ; Schmidt K
    Adv Exp Med Biol; 1983; 156():483-94. PubMed ID: 6552851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the anti-inflammtory action of pyridinolcarbamate (Anginin).
    Lykke AW; Willoughby DA; Kosche ER
    J Pathol; 1969 Mar; 97(3):527-36. PubMed ID: 5352819
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antagonism between synthetic bradykinin and phenylbutazone in the rabbit].
    LECOMTE J
    C R Seances Soc Biol Fil; 1960; 154():2389-91. PubMed ID: 13760127
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biochemistry of bradykinin and kallidin].
    Iwanaga S; Suzuki T
    Seikagaku; 1967 Mar; 39(3):137-51. PubMed ID: 4863331
    [No Abstract]   [Full Text] [Related]  

  • 35. ENDOGENEOUS PERMEABILITY FACTORS AND THEIR INHIBITORS AFFECTING VASCULAR PERMEABILITY IN CUTANEOUS ARTHUS REACTIONS AND THERMAL INJURY.
    HAYASHI H; YOSHINAGA M; KOONO M; MIYOSHI H; MATSUMURA M
    Br J Exp Pathol; 1964 Aug; 45(4):419-35. PubMed ID: 14203198
    [No Abstract]   [Full Text] [Related]  

  • 36. [Identification of kinins releasing by pig pancreatic kallikrein from rabbit low molecular weight kininogen].
    Paskhina TS; Makevnina LG; Egorova TP; Levina GO
    Biokhimiia; 1977 Jun; 42(6):1144-7. PubMed ID: 889975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors.
    Griesbacher T
    Pharmacology; 2000 Apr; 60(3):113-20. PubMed ID: 10754447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of some peptides on bronchial muscle.
    BHOOLA KD; COLLIER HO; SCHACHTER M; SHORLEY PG
    Br J Pharmacol Chemother; 1962 Aug; 19(1):190-7. PubMed ID: 13868845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cold promoted activation of factor VII. 3. Relation to the kallikrein system.
    Gjonnaess H
    Thromb Diath Haemorrh; 1972 Oct; 28(2):182-93. PubMed ID: 4639652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.